ImmunityBio, Inc. (IBRX)
NASDAQ: IBRX · Real-Time Price · USD
6.70
+0.44 (7.03%)
At close: Nov 18, 2026, 4:00 PM EST
6.70
0.00 (0.00%)
Pre-market: Nov 19, 2026, 8:37 AM EST
ImmunityBio Market Cap
ImmunityBio has a market cap or net worth of $7.13 billion as of November 18, 2026. It is the 2,693rd most valuable company in the world and the 919th biggest in the United States. Its market cap has increased by 256.47% in one year.
Market Cap
7.13B
Enterprise Value
8.09B
1-Year Change
256.47%
Global Rank
Country Rank
#919 United States
Category
ChartMarket Cap Chart
Since March 10, 2021, ImmunityBio's market cap has decreased from $14.82B to $7.13B, a decrease of -51.92%. That is a compound annual growth rate of -12.06%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 18, 2026 | 7.13B | 265.48% |
| Dec 31, 2025 | 1.95B | 4.33% |
| Dec 31, 2024 | 1.87B | -44.23% |
| Dec 29, 2023 | 3.35B | 61.49% |
| Dec 30, 2022 | 2.08B | -14.18% |
| Dec 31, 2021 | 2.42B | -83.68% |
| Mar 10, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| ABIVAX Société Anonyme | 7.29B |
| Axsome Therapeutics | 7.25B |
| Immunovant | 7.01B |
| Oruka Therapeutics | 6.90B |
| Kodiak Sciences | 6.72B |
| Belite Bio | 6.64B |
| Twist Bioscience | 6.61B |
| Arrowhead Pharmaceuticals | 6.44B |